Personal information

Activities

Employment (2)

Oslo University Hospital: Oslo, NO

(Department of Clinical Cancer Research)
Employment
Source: Self-asserted source
Nikolai Kragøe Andresen

Oslo University Hospital: Oslo, NO

PhD student (Department of Cancer Immunology)
Employment
Source: Self-asserted source
Nikolai Kragøe Andresen

Works (7)

Gut microbiota diversity is prognostic and associated with benefit from chemo‐immunotherapy in metastatic triple‐negative breast cancer

Molecular Oncology
2024-11-15 | Journal article
Contributors: Andreas Ullern; Kristian Holm; Andreas Hagen Røssevold; Nikolai Kragøe Andresen; Corinna Bang; Ole Christian Lingjærde; Bjørn Naume; Johannes R. Hov; Jon Amund Kyte
Source: check_circle
Crossref

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

Molecular Oncology
2024-07-08 | Journal article
Contributors: Nikolai Kragøe Andresen; Andreas Hagen Røssevold; Elin Borgen; Cecilie Bendigtsen Schirmer; Bjørnar Gilje; Øystein Garred; Jon Lømo; Marius Stensland; Oddmund Nordgård; Ragnhild Sørum Falk et al.
Source: check_circle
Crossref

Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation

npj Breast Cancer
2024-04-23 | Journal article
Contributors: Sudhir Kumar Chauhan; Claire Dunn; Nikolai Kragøe Andresen; Andreas Hagen Røssevold; Gjertrud Skorstad; Adam Sike; Bjørnar Gilje; Sunil Xavier Raj; Kanutte Huse; Bjørn Naume et al.
Source: check_circle
Crossref

Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial

Journal for ImmunoTherapy of Cancer
2024-01 | Journal article
Contributors: Nikolai Kragøe Andresen; Andreas Hagen Røssevold; Claire Quaghebeur; Bjørnar Gilje; Beate Boge; Andrea Gombos; Ragnhild Sørum Falk; Randi R. Mathiesen; Lars Julsrud; Øystein Garred et al.
Source: check_circle
Crossref

Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial

Nature Medicine
2022-12 | Journal article
Contributors: Andreas Hagen Røssevold; Nikolai Kragøe Andresen; Christina Annette Bjerre; Bjørnar Gilje; Erik Hugger Jakobsen; Sunil Xavier Raj; Ragnhild Sørum Falk; Hege Giercksky Russnes; Thea Jahr; Randi Ruud Mathiesen et al.
Source: check_circle
Crossref

215MO ICON – a randomized phase IIb study evaluating chemotherapy combined with ipilimumab and nivolumab in metastatic hormone receptor-positive breast cancer

Annals of Oncology
2022-09 | Conference abstract
Part of ISSN: 0923-7534
Contributors: Nikolai Kragøe Andresen
Source: Self-asserted source
Nikolai Kragøe Andresen

ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer.

Journal of translational medicine
2020-07 | Journal article
Contributors: Kyte JA; Andresen NK; Russnes HG; Fretland SØ; Falk RS; Lingjærde OC; Naume B
Source: Self-asserted source
Nikolai Kragøe Andresen via Europe PubMed Central